These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1290959)

  • 1. The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
    Wingard JR
    Leuk Lymphoma; 1992 Nov; 8(4-5):353-9. PubMed ID: 1290959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
    Wingard JR; Merz WG; Rinaldi MG; Miller CB; Karp JE; Saral R
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1847-9. PubMed ID: 8239594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
    Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
    Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team.
    Chandrasekar PH; Gatny CM
    Chemotherapy; 1994; 40(2):136-43. PubMed ID: 8131635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
    Slavin MA; Osborne B; Adams R; Levenstein MJ; Schoch HG; Feldman AR; Meyers JD; Bowden RA
    J Infect Dis; 1995 Jun; 171(6):1545-52. PubMed ID: 7769290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
    Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G
    J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.
    Chandrasekar PH; Gatny CM
    J Antimicrob Chemother; 1994 Feb; 33(2):309-18. PubMed ID: 8182012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis in bone marrow transplantation.
    Milliken ST; Powles RL
    Rev Infect Dis; 1990; 12 Suppl 3():S374-9. PubMed ID: 2184515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
    Johansen HK; Gotzsche PC
    Cochrane Database Syst Rev; 2000; (3):CD000239. PubMed ID: 10908468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
    Minari A; Hachem R; Raad I
    Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal prophylaxis in bone marrow transplant.
    Lam HH; Althaus BL
    Ann Pharmacother; 1995 Sep; 29(9):921-4. PubMed ID: 8547742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.